Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
mTOR & rapamycin
Video summary

Rapamycin from Easter Island: described anti-aging research

The description says rapamycin, originally from Easter Island, was found to slow cell division and is now studied for possibly slowing aging and delaying age-related diseases by inhibiting mTOR. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The description says rapamycin originally comes from Easter Island and was found to slow cell division. [1]

  2. The description says rapamycin is now studied for possibly slowing aging and delaying age-related diseases by inhibiting mTOR. [1]

  3. The description says the clip comes from Dr. Kaeberlein's interview on the Adding Years podcast. [1]

The source at a glance

Study type / format
Short video description (podcast interview excerpt)
Population / context
Cells and aging research mentioned in the video description; no human participants described.
Summary based on
Creator description
Original publication
July 16, 2026

Rapamycin's origin and early cell-division finding

The description presents rapamycin as a powerful drug that originally comes from Easter Island. It states that the drug was discovered to slow cell division. The description gives no details on who made this observation, in which cells or organisms it was seen, or how large the effect was.

Supporting source [1]

mTOR inhibition and studied aging outcomes

According to the description, rapamycin is now studied for its potential to slow aging and to delay age-related diseases. It attributes this potential to inhibition of mTOR. The wording describes research interest and potential, not demonstrated benefits for human lifespan or health. The description does not report study design, participants, doses or results.

Supporting source [1]

Clip source: Kaeberlein interview excerpt

The description says this short clip is taken from Dr. Kaeberlein's interview on the Adding Years podcast and links to the full interview. It does not say what was measured, in which species, or whether any human outcome was shown.

Supporting source [1]

How to interpret this

Only the video description was reviewed; the video and transcript were not reviewed. The description gives no study design, species, sample, dose or results, so it cannot show that rapamycin slows human aging.

Based on the creator’s description; the full video and transcript were not analyzed.

Source & supporting passages

[1]
Rapamycin: The Anti-Aging Drug From Easter Island? #shorts

Matt Kaeberlein · youtube.com · July 16, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    originally from Easter Island
  2. Finding 2 ↑

    inhibiting mTOR
  3. Finding 3 ↑

    interview on the Adding Years podcast

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…